1 completed, 1 unknown. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Unknown 1 |
Follow CP protocol: new trials by email Literature Review of CP protocol trials Research Report on CP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC TAK-676, Carboplatin, 5-FU - Head and Neck Squamous Cell Carcinoma | Early Phase 1 | Completed | Presage Biosciences | 15 | 2021-07-26 | 2023-10-06 |
| A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer Sintilimab, carboplatin/paclitaxel, Radiation - Esophageal Squamous Cell Carcinoma | Early Phase 1 | Unknown | Zhejiang Cancer Hospital | 20 | 2019-05-01 | 2019-09-09 |
Esophageal Squamous Cell Carcinoma (1) · Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Presage Biosciences (1) · Zhejiang Cancer Hospital (1)
China (1) · United States (1)
Wendy Jenkins (1)